Pharma Lösungen – Analytische Lösungen für die pharmazeutische Industrie

The pharmaceutical industry places the highest demands on quality, safety, and reproducibility. Differences in crystal structure, polymorphism, chemical composition, or internal product structure have a significant impact on the efficacy, bioavailability, stability, and manufacturability of pharmaceutical products. Reliable analytical characterisation across the entire pharmaceutical workflow is therefore essential.

Rigaku offers comprehensive pharmaceutical solutions for the pharmaceutical industry, enabling precise pharmaceutical analytics from active pharmaceutical ingredient (API) development and formulation development through to pharmaceutical production and quality control. The analytical techniques employed deliver robust data on the structural, thermal, chemical, and morphological properties of pharmaceutical materials.

In the early stages of development, analytical solutions support the characterisation of APIs, excipients, and intermediates. Methods such as X-ray diffraction (XRD) and thermal analysis enable the identification of polymorphs, the investigation of phase transitions, and the assessment of stability, even with very small sample quantities. In this way, development risks can be minimised at an early stage and suitable solid-state forms can be selectively identified.

During formulation development and the manufacture of dosage forms, non-destructive X-ray CT analyses provide three-dimensional insights into tablets, pellets, and lyophilised products. Porosity, crack formation, layer structures, and inhomogeneities can be quantitatively assessed without damaging the product, supporting the optimisation of manufacturing processes.

In pharmaceutical production and quality control, X-ray fluorescence- and Raman-based solutions enable rapid identification of raw materials, the analysis of trace elements and impurities at ppm levels, as well as the monitoring of polymorphism and composition.

With these integrated analytical solutions, Rigaku supports companies in meeting regulatory requirements, shortening development timelines, and ensuring high product quality throughout the entire lifecycle of pharmaceutical products.

Download the brochure now and learn how holistic analysis strategies reduce development and production risks and ensure the long-term quality of pharmaceutical products.